Generer rapport
Hamlet Protein A/S
Saturnvej 51, 8700 Horsens, CVR 16049441
Virksomhedsform
Aktieselskab
Etableret
1992
Størrelse
Mellemstore
Ansatte
57
Omsætning
453
MDKK
Bruttofortj.
-7.135.000
DKK
Primært resultat (EBIT)
-93.460.000
DKK
Årets resultat
-87.791.000
DKK
Egenkapital
59
MDKK
annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
44/45
"Bund 10%"
Rang i Danmark
343.414/344.121
"Bund 10%"
Direktion top 3
Erik Robert Visser 1 | CEO |
Bestyrelse top 3
Søren Dan Johansen 27 | Bestyrelsesformand |
Donald William Christopher Mallon 1 | Næstformand |
Sarah Vawda 1 | Bestyrelsesmedlem |
Legale ejere top 3
100% | New Nutrition Aps | DK |
Tegningsregler
Selskabet tegnes af bestyrelsesformanden og en næstformand i forening eller af den samlede bestyrelse.
Stamoplysninger baseret på CVR
Navn | Hamlet Protein A/S |
CVR | 16049441 |
Adresse | Saturnvej 51, 8700 Horsens |
Branche | Fremstilling af færdige foderblandinger til landbrugsdyr [109100] |
Etableret | 16-03-1992 (32 år) |
Første regnskabsperiode | 01-01-1992 til 31-12-1992 |
Virksomhedsform | Aktieselskab |
Antal ansatte | 55 (årsværk:55) |
Reklamebeskyttelse | Nej |
Revisor | Deloitte Statsautoriseret Revisionspartnerselskab siden 11-05-2017 |
Regnskabsperiode | 01-01 til 31-12 |
Selskabskapital | 4.710.000 DKK 1.210.000 DKK (01-09-2006 - 21-12-2008) 2.420.000 DKK (18-05-1994 - 31-08-2006) 2.200.000 DKK (04-11-1992 - 17-05-1994) 2.000.000 DKK (13-05-1992 - 03-11-1992) 1.000.000 DKK (01-04-1992 - 12-05-1992) |
Vedtægter seneste | 08-01-2024 |
Medlem af brancherne
- Fremstilling af færdige foderblandinger til landbrugsdyrNACE6 indeholdende 68 virk.
- Fremstilling af færdige foderblandingerNACE3 indeholdende 103 virk.
- Fremstilling af fødevarerNACE2 indeholdende 2.311 virk.
- FremstillingsvirksomhedNACE1 indeholdende 26.294 virk.
Formål
Selskabets formål er handel og industriel produktion.
Regnskab
2022 | 2021 | 2020 | |
---|---|---|---|
Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
Omsætning | 452.988 -6% | 481.036 -2% | 491.884 +35% |
Bruttofortjeneste | -7.135 - | 52.477 -44% | 92.928 +22% |
Årets resultat | -87.791 - | -13.126 - | 1.351 - |
Egenkapital | 59.375 -59% | 144.698 -5% | 152.464 -3% |
Balance | 523.968 +1% | 520.748 -7% | 559.125 +10% |
Ledelsesberetning
Development in activities and financesNon-financial matters
Quality
Both HAMLET PROTEIN plants in Denmark and USA meet the criteria of the feed safety standard GMP+ and the food safety
management standard ISO 22000. Our strict Feed Safety Policy ensures full traceability of both GMO and non-GMO products, allowing any batch of product to be easily traced if need be. Every week, the Company’s laboratory teams analyze 200 protein samples, taken around-the-clock from our production lines. These analyses are an important part of our customer service and a guarantee of high product quality. The sector specific knowledge and competences of the employees form an important foundation for HAMLET PROTEIN’s leading position in young animal nutrition and are a driver for future business development.
Shareholders
HAMLET PROTEIN is owned by New Nutrition Holding S.àr.l., Luxembourg, which ultimately is owned by Goldman Sachs Group Inc. (“GS Group”) and Altor Fund IV Holding AB. The Company's share capital is not divided into share classes, and the Company's articles of association do not stipulate any limits for ownership or voting rights. The Board of Directors regularly assesses whether the Company's capital structure is sound and capable of supporting the Company's growth strategy.
The Board of Directors' duties
The Board of Directors of the Company ensures that the Executive Board complies with the decisions, strategies,
and business procedures adopted by the Board of Directors. The Board of Directors meets according to a fixed schedule. In 2022, the Board of Directors held five meetings. For 2023 four meetings have been scheduled.
The Board of Directors does not rely on any subcommittees due to the limited size and complexity of the Group. Accordingly, the entire Board of Directors has focused on significant accounting policies and significant accounting estimates, and transactions with related parties, if any, as well as uncertainties and risks in its financial reporting process. Together with the auditors, the quality of the Company's internal control systems is being assessed on a regular basis, just as the auditors' independence is verified. Areas identified as particularly critical, such as foreign currency policy, procurement policy and insurance matters, are regularly discussed within the
Board of Directors.
Group relations
Recommendations for active ownership and corporate governance for private equity funds
Being owned by private equity funds, New Nutrition Holding ApS is subject to the guidelines for active ownership and corporate governance for private equity funds and their controlled enterprises as issued by the Danish Venture Capital and Private Equity Association ("DVCA"). In general, New Nutrition Holding ApS complies with these recommendations apart from the incidents where the Company's management assesses that the disclosure of specific information will be detrimental to the Group's and the Company's competitive situation.
Quality
Both HAMLET PROTEIN plants in Denmark and USA meet the criteria of the feed safety standard GMP+ and the food safety
management standard ISO 22000. Our strict Feed Safety Policy ensures full traceability of both GMO and non-GMO products, allowing any batch of product to be easily traced if need be. Every week, the Company’s laboratory teams analyze 200 protein samples, taken around-the-clock from our production lines. These analyses are an important part of our customer service and a guarantee of high product quality. The sector specific knowledge and competences of the employees form an important foundation for HAMLET PROTEIN’s leading position in young animal nutrition and are a driver for future business development.
Shareholders
HAMLET PROTEIN is owned by New Nutrition Holding S.àr.l., Luxembourg, which ultimately is owned by Goldman Sachs Group Inc. (“GS Group”) and Altor Fund IV Holding AB. The Company's share capital is not divided into share classes, and the Company's articles of association do not stipulate any limits for ownership or voting rights. The Board of Directors regularly assesses whether the Company's capital structure is sound and capable of supporting the Company's growth strategy.
The Board of Directors' duties
The Board of Directors of the Company ensures that the Executive Board complies with the decisions, strategies,
and business procedures adopted by the Board of Directors. The Board of Directors meets according to a fixed schedule. In 2022, the Board of Directors held five meetings. For 2023 four meetings have been scheduled.
The Board of Directors does not rely on any subcommittees due to the limited size and complexity of the Group. Accordingly, the entire Board of Directors has focused on significant accounting policies and significant accounting estimates, and transactions with related parties, if any, as well as uncertainties and risks in its financial reporting process. Together with the auditors, the quality of the Company's internal control systems is being assessed on a regular basis, just as the auditors' independence is verified. Areas identified as particularly critical, such as foreign currency policy, procurement policy and insurance matters, are regularly discussed within the
Board of Directors.
Group relations
Recommendations for active ownership and corporate governance for private equity funds
Being owned by private equity funds, New Nutrition Holding ApS is subject to the guidelines for active ownership and corporate governance for private equity funds and their controlled enterprises as issued by the Danish Venture Capital and Private Equity Association ("DVCA"). In general, New Nutrition Holding ApS complies with these recommendations apart from the incidents where the Company's management assesses that the disclosure of specific information will be detrimental to the Group's and the Company's competitive situation.
28-04-2023